一名2019冠状病毒病再次感染患者的血清抗体谱
Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection.
作者信息
To Kelvin Kai-Wang, Hung Ivan Fan-Ngai, Chan Kwok-Hung, Yuan Shuofeng, To Wing-Kin, Tsang Dominic Ngai-Chong, Cheng Vincent Chi-Chung, Chen Zhiwei, Kok Kin-Hang, Yuen Kwok-Yung
机构信息
State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
出版信息
Clin Infect Dis. 2021 May 18;72(10):e659-e662. doi: 10.1093/cid/ciaa1368.
Abstract
We recently reported a patient with coronavirus disease 2019 reinfection. Here, we show that serum neutralizing antibodies could be detected during the first episode but not at the presentation of the second episode. During reinfection, neutralizing antibodies and high avidity immunoglobulin G were found within 8 days after hospitalization, whereas immunoglobulin M response was absent.
摘要
我们最近报告了一例2019冠状病毒病再次感染的患者。在此，我们表明在首次发病期间可检测到血清中和抗体，但在第二次发病时未检测到。在再次感染期间，住院后8天内发现了中和抗体和高亲和力免疫球蛋白G，而未出现免疫球蛋白M反应。
相似文献
1
Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection.一名2019冠状病毒病再次感染患者的血清抗体谱
Clin Infect Dis. 2021 May 18;72(10):e659-e662. doi: 10.1093/cid/ciaa1368.
2
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response.比利时医院感染暴发中，一名医护人员出现有症状的严重急性呼吸综合征冠状病毒 2 再感染，尽管存在初级中和抗体反应。
Clin Infect Dis. 2021 Nov 2;73(9):e2985-e2991. doi: 10.1093/cid/ciaa1850.
3
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.一例 COVID-19 再感染病例：抗体在 SARS-CoV-2 感染中的作用。
CEN Case Rep. 2022 Nov;11(4):422-427. doi: 10.1007/s13730-022-00697-z. Epub 2022 Mar 9.
4
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.SARS-CoV-2 特异性抗体分泌细胞的扩增和住院 COVID-19 患者中中和抗体的产生。
J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2.
5
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.SARS-CoV-2 再感染，尽管存在可检测的中和抗体。
Viruses. 2021 Apr 12;13(4):661. doi: 10.3390/v13040661.
6
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
7
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征（MIS-C）中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
8
A case with SARS-CoV-2 reinfection from India.印度出现 SARS-CoV-2 再感染病例。
Indian J Med Microbiol. 2022 Jan-Mar;40(1):166-168. doi: 10.1016/j.ijmmb.2021.09.010. Epub 2021 Nov 15.
9
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.等离子体基表面上血清和唾液中 SARS-CoV-2 抗体的抗体亲和力定量和准确检测。
Nat Biomed Eng. 2020 Dec;4(12):1188-1196. doi: 10.1038/s41551-020-00642-4. Epub 2020 Oct 29.
10
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.SARS-CoV-2 特异性中和抗体反应在 COVID-19 大流行第一波后挪威医护人员中的前瞻性队列研究。
J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737.
引用本文的文献
1
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.与新型冠状病毒再次感染相关的临床和基因组特征识别
Viruses. 2025 Jun 11;17(6):840. doi: 10.3390/v17060840.
2
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.评估 SARS-CoV-2 感染和接种疫苗后的血清学检测抗体动态和中和活性。
PLoS One. 2023 Sep 19;18(9):e0291670. doi: 10.1371/journal.pone.0291670. eCollection 2023.
3
Immune landscape and redox imbalance during neurological disorders in COVID-19.新冠病毒感染相关神经疾病中的免疫景观与氧化还原失衡。
Cell Death Dis. 2023 Sep 6;14(9):593. doi: 10.1038/s41419-023-06102-6.
4
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征：一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
5
SARS-CoV-2 reinfection across a spectrum of immunological states.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在一系列免疫状态下的再次感染。
Health Sci Rep. 2022 Jul 22;5(4):e554. doi: 10.1002/hsr2.554. eCollection 2022 Jul.
6
Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 Vaccination.新冠疫苗接种后六个月内抗生素近期使用情况与免疫原性之间的关联
Vaccines (Basel). 2022 Jul 14;10(7):1122. doi: 10.3390/vaccines10071122.
7
COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants.COVID-19疫苗接种策略及其对SARS-CoV-2变体出现的适应性
Vaccines (Basel). 2022 Jun 6;10(6):905. doi: 10.3390/vaccines10060905.
8
Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection.新型冠状病毒再次感染患者的临床特征与转归
Mayo Clin Proc Innov Qual Outcomes. 2022 Aug;6(4):361-372. doi: 10.1016/j.mayocpiqo.2022.05.004. Epub 2022 May 30.
9
Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.免疫性疾病和利妥昔单抗输注对 COVID-19 感染复发的影响。
Perm J. 2021 Oct 29;26(1):123-131. doi: 10.7812/TPP/21.035.
10
COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted.COVID-19 疫苗和公众焦虑：抗体检测可能会被广泛接受。
Front Public Health. 2022 May 6;10:819062. doi: 10.3389/fpubh.2022.819062. eCollection 2022.
Zotero 插件